When an outbreak of mpox first hit the United States in 2022, a vaccine called Jynneos was available to help protect the most ...

Surging mpox cases in East, West and Central Africa prompted the World Health Organization to once again make the infection a ...

The Japanese-made vaccine should arrive in the country as early as next week, as the number of cases continues to surge.

More than 500 cases of unknown illness have emerged in rural, remote Panzi in western Democratic Republic of the Congo.

Mpox vaccines that young children can use will arrive from Japan next week, a crucial step in reducing the spread of the ...

Democratic Republic of Congo should start to receive three million doses of mpox vaccine from Japan next week that can be ...

CIDRAP: Recombinant Pertussis Vaccine May Protect Teens For At Least 5 Years Researchers report that immunity against pertussis (whooping cough) was sustained 5 years after receipt of a ...

It’s déjà vu for Siga Technologies and its smallpox antiviral Tpoxx. At an interim analysis of a second mpox trial, the drug ...

In this Review, we examine the concurrent outbreaks of mpox in Africa, focusing on clade 1a, the newly emerged clade 1b, and ...

Danish pharma company Bavarian Nordic is shutting down its U.S.-based R&D site in San Diego and laying off all 48 employees ...

Another trial for SIGA Technologies' mpox antiviral has failed, and all enrollment has been stopped, the NIH's National ...

Interim data from a phase 3 study evaluating tecovirimat for the treatment of human mpox virus showed the antiviral did not improve time to lesion resolution compared with placebo.